Cramer's Lightning Round - Isis Pharmaceuticals Has One Of The Best Pipelines In The Industry (6/12/14)

by: Miriam Metzinger

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday June 12.

Bullish Calls:

  • Isis Pharmaceuticals (ISIS): "I think Isis is a long-term situation ... it has the best pipeline in the industry (aside from Seattle Genetics). I think you buy it. It is speculative, but I like it."
  • Sysco (NYSE:SYY): "I think it is headed higher. It has a good yield, and it is making acquisitions."
  • Pfizer (NYSE:PFE), Bristol-Myers (NYSE:BMY): "I think PFE is fine. It is doing a good job. I prefer Bristol-Myers, but Pfizer is fine."
  • Lazard (NYSE:LAZ): "It is a good buy. That is precisely where I want to be."

Bearish Calls:

  • Trinity (NYSE:TRN): "I don't like the way Trinity acts. It seems that margins have peaked in the rail business. I don't want to own Trinity."
  • Himax Technologies (NASDAQ:HIMX): "We had a great trade in Himax, we took profits, and we're not looking back."
  • Chimera Investment (NYSE:CIM): "This is a yield play. I always expected more of it. It is not a great place to be."


Jim Cramer’s Action Alerts PLUS: Check out Cramer’s multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.